How much does a box of Lenalidomide cost?

Lenalidomide (Lenalidomide) is an immunomodulatory drug that belongs to a class of targeted drugs. It is usually used to treat a variety of blood diseases, especially multiple myeloma (Multiple Myeloma) and high-risk myelodysplastic syndrome (Myelodysplastic Syndromes, MDS).

Lenalidomide has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The price is around 3,500~4,000 yuan. Due to different medical insurance policies in various places, the price also varies. Please consult your local pharmacy for specific prices. There are also original research drugs in China, but the price is as high as tens of thousands of yuan, so it is not recommended to buy them. The cheaper ones abroad are mainly generic drugs, including those from India, Bangladesh, and Laos, which cost about a few hundred yuan per box. The ingredients of foreign generic drugs and domestic lenalidomide drugs are basically the same.

Lenalidomide is often used with other drugs, such as dexamethasone, to treat multiple myeloma, a malignant blood disease in which plasma cells in the bone marrow grow abnormally. Lenalidomide helps control the progression of the disease through multiple mechanisms, including inhibiting the growth of tumor cells and promoting immune system activity.

High-riskMDSPatients may be treated with lenalidomide to improve bone marrow hematopoiesis. MDSA group of bone marrow disorders that often present with anemia, bleeding tendencies and susceptibility to infections, and lenalidomide can help improve patients' blood counts.

Lenalidomide has multiple immunomodulatory mechanisms. It can enhance the activity of the immune system and increase the number and function of immune effector cells to help the body fight against tumor cells. At the same time, it can also inhibit the growth and spread of tumor cells.

Although lenalidomide usually has milder side effects than traditional chemotherapy drugs, it may still cause some discomfort, such as fatigue, anemia, skin reactions, digestive tract problems, etc. Therefore, physician supervision and regular monitoring are required when using lenalidomide.

In short, lenalidomide is a targeted drug mainly used to treat malignant hematological diseases, helping patients control the disease by regulating the immune system and affecting the growth of tumor cells. It has made significant progress in improving survival and quality of life in patients with multiple myeloma and high-risk MDS, but it still needs to be used rationally under physician supervision to ensure optimal efficacy and safety.